3 min read Business Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US June 4, 2022 Bharat Herald OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients...
